Literature DB >> 24327970

Management of sizeable carotid body tumor: Case report and review of literature.

Mohamed A Elsharawy1, Hind Alsaif, Aymen Elsaid, Ali Kredees.   

Abstract

Carotid body tumor is a paraganglioma derived from the neural crest. It arises from the carotid body which acts as a vascular chemoreceptors and is usually located at the carotid bifurcation. Sizeable (Shamblin III, >5 cm size) tumors are large and typically encase the carotid artery requiring vessel resection and replacement. Management of such tumors carries a high risk of postoperative mortality and morbidity rates specially with regards to neurovascular complications. We report a case of sizeable tumor which was surgically removed with minimal complications.

Entities:  

Keywords:  Carotid body tumor; Shamblin; paraganglioma

Year:  2013        PMID: 24327970      PMCID: PMC3841480          DOI: 10.4103/2231-0770.120503

Source DB:  PubMed          Journal:  Avicenna J Med        ISSN: 2231-0770


INTRODUCTION

CBT is a rare neck tumor that is derived from the neural crest.[1] Management of sizeable (Shamblin III, >5 cm size) tumors carries a high risk of postoperative mortality and morbidity rates specially with regards to neurovascular complications.[2] We report a case of sizeable tumor which was surgically removed with minimal blood loss, temporary neurological loss, and no cerebro vascular complications. No preoperative embolization was performed. Review of literature[3] and our case reveals that proper surgical technique is the key to improve treatment outcome.

CASE REPORT

A 40-year-old Yemini woman was admitted to King Fahd Hospital of University, Alkhobar, Saudi Arabia with a progressively growing mass in the left anterolateral side of her neck of 5 years duration. She presented with neck tenderness, dizziness, increasing number of fainting attacks, and shortness of breath. There was no history of hoarseness, dysphagia, or palpitation and no family history of a similar condition. Her left pupil was slightly more contracted than the right pupil (Horner's syndrome). The rest of her neurologic examination was unremarkable. Indirect laryngoscopy revealed slightly impaired movement of left vocal cord. Contrast enhanced computed tomography (CECT) scan of the neck with subsequent CT angiograms of the carotids showed a 6.9 × 5 × 5.8 cm hypervascular solid left carotid space mass encasing the common carotid artery (CCA) and both internal CA (ICA) and external CA (ECA) and splaying the carotid bifurcation with no luminal narrowing or thrombosis [Figures 1 and 2]. There was no contralateral tumor. The tumor was diagnosed as carotid body paraganglioma of Shamblin group III. Horner's syndrome was due to tumor encasement of the left sympathetic chain. No preoperative embolization was performed. The tumor was surgically removed under locoregional anesthesia and supplemented with intravenous propofol after reconstruction of the CA. The hypoglossal and vagus nerves were identified during surgery and preserved. Part of CCA, ICA, and ECA were removed with tumor and ICA was reconstructed with polytetrafluroethylene (PTFE) graft [Figures 3 and 4]. Monitoring of the neurological status was achieved by simple clinical evaluation of the state of consciousness under local anesthesia, and by continuous regional oxygen saturation (rSO2), measured with a cerebral oximeter (Somanetics Invos cerebral oximeter). It was not necessary to place a shunt. Blood loss was about 450 ml. Postoperatively, a transient swallowing difficulty and tongue deviation developed probably due to stretching of the hypoglossal nerve during the operation. On laryngoscopic examination, left-sided vocal cord paralysis was aggravated. There was no cerebrovascular event after surgery. Histopathology examination confirmed the preoperative diagnosis of paraganglioma [Figure 5]. Six months after surgery, the patient could speak and swallow normally and her tongue deviation disappeared. Graft surveillance at 9 months revealed a patent graft with normal flow.
Figure 1

(a) Hypervascular left carotid space mass (M) splaying and encasing the internal carotid artery (ICA; long arrow) and the external CA (ECA; short arrow). (b) The common CA (CCA) was also encased (*), findings are in keeping with type III A1, A2, and A3 carotid body tumor. Hypertrophied left descending pharyngeal artery (arrow)

Figure 2

Computed tomography angiography (CTA) carotids (a) 3D: carotid body tumor with splaying of the carotid bifurcation (*). Note: Hypertrophied left descending pharyngeal artery (arrow). (b) Coronal reformats: Significant mass effect on the left internal jugular vein which appears markedly compressed

Figure 3

Perioperative finding of left side tumor. A huge hypervascular tumor surrounds the left common, internal, and external carotid arteries

Figure 4

Internal carotid artery was reconstructed with polytetrafluroethylene (PTFE) graft

Figure 5

Well-defined nests of cuboidal cells (zellballen) are separated by highly vascularized fibrous septa (hematoxylin and eosin (H and E, ×400)

(a) Hypervascular left carotid space mass (M) splaying and encasing the internal carotid artery (ICA; long arrow) and the external CA (ECA; short arrow). (b) The common CA (CCA) was also encased (*), findings are in keeping with type III A1, A2, and A3 carotid body tumor. Hypertrophied left descending pharyngeal artery (arrow) Computed tomography angiography (CTA) carotids (a) 3D: carotid body tumor with splaying of the carotid bifurcation (*). Note: Hypertrophied left descending pharyngeal artery (arrow). (b) Coronal reformats: Significant mass effect on the left internal jugular vein which appears markedly compressed Perioperative finding of left side tumor. A huge hypervascular tumor surrounds the left common, internal, and external carotid arteries Internal carotid artery was reconstructed with polytetrafluroethylene (PTFE) graft Well-defined nests of cuboidal cells (zellballen) are separated by highly vascularized fibrous septa (hematoxylin and eosin (H and E, ×400)

DISCUSSION

CBT is a paraganglioma arising from the carotid body which acts as a vascular chemoreceptors and is usually located at the carotid bifurcation.[2] Although most of CBT are benign and slow growing, early excision is recommended because of the unpredictable malignancy potential. Even if the tumor is not pathologically malignant, it will continue to grow and can cause various complications and will become too difficult for a surgeon to remove without complications.[4] In 1971, Shamblin et al., introduced a classification system based on the size of the tumor into groups I, II, and III.[5] Group III, like the present case, consists of tumors that are large and typically encase the CA requiring vessel resection and replacement. Most of the previous studies reported high rate of neurovascular complication (23-47%)[267] with Shamblin III tumors. The risk seems to be more significant when the tumor size is more than 5 cm[8] (similar to the present case). Therefore, early detection and prompt surgical resection of CBTs will decrease surgical morbidity.[2] Nevertheless, early detection of the small tumor is difficult because of the limited clinical symptoms during its early stage.[9] In large tumors, neurovascular symptoms and signs, such as hoarseness, vocal cord paralysis, dysphasia, Horner's syndrome, carotid pulsations, thrill, and symptoms of cerebral ischemia or carotid sinus syndrome, are usually present.[9] In this case, Horner's syndrome was detected. Noninvasive imaging studies like CT scan with contrast and magnetic resonance imaging (MRI) are useful modalities to identify CBT.[10] In our case, CT with contrast was enough for the diagnosis. CT demonstrated a solid mass that showed homogenous enhancement on intravenous contrast administration. The presence of uniform contrast enhancement and large feeding vessels into the tumor excludes enlarged lymph nodes and schwannomas. Carotid angiography can demonstrate the tumor hypervascularity and widening of the carotid bifurcation by a well-defined tumor blush (“Lyre sign”), which is a pathognominic angiographic finding. Selective embolization can be used to reduce the size of tumor and bleeding complications during surgery.[11] However, other studies showed that embolization has no significant effect on intraoperative blood loss or operation time[2] and was not effective in reducing neurological complications.[12] In our case there were multiple arteries supplying the tumor making super selective embolization very difficult. Fortunately, blood loss was not significant. Cerebrovascular accidents are the most serious postoperative complication and have been reported to be up to 11%.[13] The balloon test occlusion of the ICA was not performed in this case since its predictive value is low.[14] We did not have to use carotid shunt since neurological status and rSO2 were maintained normal during the whole procedure. There was no evidence of vascular insufficiency after surgery. Although autogenous vein graft has better patency rates than PTFE in peripheral arterial bypasses,[15] this advantage was not confirmed for CA bypasses.[316] The incidence of cranial nerve injury is reported as high as 40%.[17] The hypoglossal and vagus nerves are the most vulnerable to injury.[2] Both nerves were identified and preserved in the present case. In conclusion, despite the development of surgical and endovascular techniques, huge carotid body paraganglioma continue to have high incidence of pre- and postoperative complications. Carotid body paraganglioma should be removed immediately upon detection. Identification of the adjacent nerves during surgery is essential in reducing postoperative problems.
  16 in total

1.  Malignant carotid body tumor.

Authors:  William Carroll; Kerstin Stenson; Scott Stringer
Journal:  Head Neck       Date:  2004-03       Impact factor: 3.147

2.  Management for carotid body paragangliomas.

Authors:  Devender Singh; Rama Krishna Pinjala; Rama Chandra Reddy; Pulitati Venkata Naga Laxmi Satya Vani
Journal:  Interact Cardiovasc Thorac Surg       Date:  2006-08-24

3.  Predictive value of balloon test occlusion of the internal carotid artery.

Authors:  D H Segal; C Sen; J B Bederson; P Catalano; M Sacher; A L Stollman; M Lorberboym
Journal:  Skull Base Surg       Date:  1995

4.  A multicenter review of carotid body tumour management.

Authors:  M S Sajid; G Hamilton; D M Baker
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-04-02       Impact factor: 7.069

5.  Surgical management and outcome of carotid body tumours.

Authors:  Y C Por; D T H Lim; M K Teoh; K C Soo
Journal:  Ann Acad Med Singapore       Date:  2002-03       Impact factor: 2.473

6.  Surgical management of carotid body tumors.

Authors:  S J Wang; M B Wang; T M Barauskas; T C Calcaterra
Journal:  Otolaryngol Head Neck Surg       Date:  2000-09       Impact factor: 3.497

7.  Surgical treatment of carotid body paragangliomas: outcomes and complications according to the shamblin classification.

Authors:  Jae-Yol Lim; Jinna Kim; Sun Ho Kim; Sak Lee; Young Chang Lim; Jae Wook Kim; Eun Chang Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-06-30       Impact factor: 3.372

8.  Neurological complications in carotid body tumors: a 6-year single-center experience.

Authors:  Indrani Sen; Edwin Stephen; Karthik Malepathi; Sunil Agarwal; N K Shyamkumar; Suraj Mammen
Journal:  J Vasc Surg       Date:  2013-02       Impact factor: 4.268

9.  Surgical management of cervical paragangliomas.

Authors:  Lazar Davidovic; Nikola Ilic; Milovan Dimitrijevic; Vojko Dukic; Radan Dzodic
Journal:  Am Surg       Date:  2008-12       Impact factor: 0.688

10.  Femoro-popliteal bypass above knee with saphenous vein vs synthetic graft.

Authors:  Emir Solaković; Dragan Totić; Sid Solaković
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363

View more
  2 in total

1.  Carotid Body Tumor with Skull Base Extension.

Authors:  Asala H Baharoon; Mohammed A Al-Mekhlafi; Reda A Jamjoom; Talal A Al-Khatib; Mazin A Merdad; Hani Z Marzouki
Journal:  Am J Case Rep       Date:  2017-10-31

2.  Case Report: Managing a giant, high-grade carotid body tumor in a resource-limited setting.

Authors:  Sunil Munakomi; Samrita Chaudhary; Iype Cherian
Journal:  F1000Res       Date:  2017-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.